<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-03" modified="2020-10-07" version="192">
<accession>Q96J02</accession>
<accession>A6NEW4</accession>
<accession>B4E234</accession>
<accession>E1P5P3</accession>
<accession>F5H217</accession>
<accession>O43584</accession>
<accession>Q5QP37</accession>
<accession>Q5TEL0</accession>
<accession>Q96F66</accession>
<accession>Q9BY75</accession>
<accession>Q9H451</accession>
<accession>Q9H4U5</accession>
<name>ITCH_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase Itchy homolog</fullName>
<shortName>Itch</shortName>
<ecNumber evidence="18 19 21 23 24 25 30">2.3.2.26</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Atrophin-1-interacting protein 4</fullName>
<shortName>AIP4</shortName>
</alternativeName>
<alternativeName>
<fullName>HECT-type E3 ubiquitin transferase Itchy homolog</fullName>
</alternativeName>
<alternativeName>
<fullName>NFE2-associated polypeptide 1</fullName>
<shortName>NAPP1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">ITCH</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Genomics" volume="73" first="238" last="241">
<title>Human ITCH is a co-regulator of the hematopoietic transcription factor NF-E2.</title>
<authorList>
<person name="Chen X."/>
<person name="Wen S.-C."/>
<person name="Fukuda M.N."/>
<person name="Gavva N.R."/>
<person name="Hsu D.-W."/>
<person name="Akama T.O."/>
<person name="Yang-Peng T.L."/>
<person name="Shen C.K.J."/>
</authorList>
<dbReference type="PubMed" id="11318614"/>
<dbReference type="DOI" id="10.1006/geno.2001.6512"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>INTERACTION WITH NFE2</scope>
<source>
<tissue>Leukemia</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2001-03" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens mRNA for ubiquitin protein ligase Itch, complete cds.</title>
<authorList>
<person name="Miyazaki K."/>
<person name="Okamoto Y."/>
<person name="Sakamoto M."/>
<person name="Nakagawara A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Mol. Cell. Neurosci." volume="11" first="149" last="160">
<title>Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins.</title>
<authorList>
<person name="Wood J.D."/>
<person name="Yuan J."/>
<person name="Margolis R.L."/>
<person name="Colomer V."/>
<person name="Duan K."/>
<person name="Kushi J."/>
<person name="Kaminsky Z."/>
<person name="Kleiderlein J.J. Jr."/>
<person name="Sharp A.H."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="9647693"/>
<dbReference type="DOI" id="10.1006/mcne.1998.0677"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 83-903 (ISOFORM 2)</scope>
<scope>INTERACTION WITH ATN1</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="8526" last="8535">
<title>Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.</title>
<authorList>
<person name="Winberg G."/>
<person name="Matskova L."/>
<person name="Chen F."/>
<person name="Plant P."/>
<person name="Rotin D."/>
<person name="Gish G."/>
<person name="Ingham R."/>
<person name="Ernberg I."/>
<person name="Pawson T."/>
</authorList>
<dbReference type="PubMed" id="11046148"/>
<dbReference type="DOI" id="10.1128/mcb.20.22.8526-8535.2000"/>
</citation>
<scope>PROTEIN SEQUENCE OF 463-470; 503-510; 514-526; 644-665 AND 875-881</scope>
<scope>INTERACTION WITH LMP2A</scope>
<scope>MUTAGENESIS OF CYS-871</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="45267" last="45275">
<title>Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH.</title>
<authorList>
<person name="Courbard J.-R."/>
<person name="Fiore F."/>
<person name="Adelaide J."/>
<person name="Borg J.P."/>
<person name="Birnbaum D."/>
<person name="Ollendorff V."/>
</authorList>
<dbReference type="PubMed" id="12226085"/>
<dbReference type="DOI" id="10.1074/jbc.m206460200"/>
</citation>
<scope>INTERACTION WITH CBLC</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Biochim. Biophys. Acta" volume="1639" first="104" last="112">
<title>The RING-H2 protein RNF11 is differentially expressed in breast tumours and interacts with HECT-type E3 ligases.</title>
<authorList>
<person name="Kitching R."/>
<person name="Wong M.J."/>
<person name="Koehler D."/>
<person name="Burger A.M."/>
<person name="Landberg G."/>
<person name="Gish G."/>
<person name="Seth A.K."/>
</authorList>
<dbReference type="PubMed" id="14559117"/>
<dbReference type="DOI" id="10.1016/j.bbadis.2003.07.001"/>
</citation>
<scope>INTERACTION WITH RNF11</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Dev. Cell" volume="5" first="709" last="722">
<title>The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4.</title>
<authorList>
<person name="Marchese A."/>
<person name="Raiborg C."/>
<person name="Santini F."/>
<person name="Keen J.H."/>
<person name="Stenmark H."/>
<person name="Benovic J.L."/>
</authorList>
<dbReference type="PubMed" id="14602072"/>
<dbReference type="DOI" id="10.1016/s1534-5807(03)00321-6"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH HGS</scope>
<scope>MUTAGENESIS OF CYS-871</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="3738" last="3749">
<title>CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4.</title>
<authorList>
<person name="Slagsvold T."/>
<person name="Marchese A."/>
<person name="Brech A."/>
<person name="Stenmark H."/>
</authorList>
<dbReference type="PubMed" id="16888620"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601267"/>
</citation>
<scope>PHOSPHORYLATION AT THR-385 AND SER-450</scope>
<scope>INTERACTION WITH SGK3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="EMBO Rep." volume="7" first="1147" last="1153">
<title>Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains.</title>
<authorList>
<person name="Chastagner P."/>
<person name="Israel A."/>
<person name="Brou C."/>
</authorList>
<dbReference type="PubMed" id="17028573"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400822"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH DTX1</scope>
<scope>UBIQUITINATION OF DTX1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="135" last="141">
<title>Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation.</title>
<authorList>
<person name="Yang C."/>
<person name="Zhou W."/>
<person name="Jeon M.S."/>
<person name="Demydenko D."/>
<person name="Harada Y."/>
<person name="Zhou H."/>
<person name="Liu Y.C."/>
</authorList>
<dbReference type="PubMed" id="16387660"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.11.014"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH JUNB AND FYN</scope>
<scope>PHOSPHORYLATION AT TYR-420</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF TYR-343; TYR-420 AND TYR-455</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="375" first="326" last="330">
<title>Itch regulates p45/NF-E2 in vivo by Lys63-linked ubiquitination.</title>
<authorList>
<person name="Lee T.-L."/>
<person name="Shyu Y.-C."/>
<person name="Hsu T.-Y."/>
<person name="Shen C.-K.J."/>
</authorList>
<dbReference type="PubMed" id="18718448"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.07.164"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH NFE2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="76" first="1515" last="1521">
<title>Itch self-polyubiquitylation occurs through lysine-63 linkages.</title>
<authorList>
<person name="Scialpi F."/>
<person name="Malatesta M."/>
<person name="Peschiaroli A."/>
<person name="Rossi M."/>
<person name="Melino G."/>
<person name="Bernassola F."/>
</authorList>
<dbReference type="PubMed" id="18718449"/>
<dbReference type="DOI" id="10.1016/j.bcp.2008.07.028"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="32621" last="32627">
<title>Nedd4 family-interacting protein 1 (Ndfip1) is required for the exosomal secretion of Nedd4 family proteins.</title>
<authorList>
<person name="Putz U."/>
<person name="Howitt J."/>
<person name="Lackovic J."/>
<person name="Foot N."/>
<person name="Kumar S."/>
<person name="Silke J."/>
<person name="Tan S.S."/>
</authorList>
<dbReference type="PubMed" id="18819914"/>
<dbReference type="DOI" id="10.1074/jbc.m804120200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E2735" last="E2735">
<title>AIP4/Itch regulates Notch receptor degradation in the absence of ligand.</title>
<authorList>
<person name="Chastagner P."/>
<person name="Israel A."/>
<person name="Brou C."/>
</authorList>
<dbReference type="PubMed" id="18628966"/>
<dbReference type="DOI" id="10.1371/journal.pone.0002735"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>UBIQUITINATION OF NOTCH1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Biochem. J." volume="423" first="31" last="39">
<title>Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5.</title>
<authorList>
<person name="Edwards T.L."/>
<person name="Clowes V.E."/>
<person name="Tsang H.T."/>
<person name="Connell J.W."/>
<person name="Sanderson C.M."/>
<person name="Luzio J.P."/>
<person name="Reid E."/>
</authorList>
<dbReference type="PubMed" id="19580544"/>
<dbReference type="DOI" id="10.1042/bj20082398"/>
</citation>
<scope>INTERACTION WITH SPART</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="1255" last="1263">
<title>ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.</title>
<authorList>
<person name="Tao M."/>
<person name="Scacheri P.C."/>
<person name="Marinis J.M."/>
<person name="Harhaj E.W."/>
<person name="Matesic L.E."/>
<person name="Abbott D.W."/>
</authorList>
<dbReference type="PubMed" id="19592251"/>
<dbReference type="DOI" id="10.1016/j.cub.2009.06.038"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>UBIQUITINATION OF RIPK2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="EMBO J." volume="28" first="513" last="522">
<title>The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.</title>
<authorList>
<person name="Shembade N."/>
<person name="Parvatiyar K."/>
<person name="Harhaj N.S."/>
<person name="Harhaj E.W."/>
</authorList>
<dbReference type="PubMed" id="19131965"/>
<dbReference type="DOI" id="10.1038/emboj.2008.285"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RNF11</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="1324" last="1339">
<title>The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction.</title>
<authorList>
<person name="Bhandari D."/>
<person name="Robia S.L."/>
<person name="Marchese A."/>
</authorList>
<dbReference type="PubMed" id="19116316"/>
<dbReference type="DOI" id="10.1091/mbc.e08-03-0308"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH CXCR4</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Nat. Immunol." volume="10" first="1300" last="1308">
<title>PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.</title>
<authorList>
<person name="You F."/>
<person name="Sun H."/>
<person name="Zhou X."/>
<person name="Sun W."/>
<person name="Liang S."/>
<person name="Zhai Z."/>
<person name="Jiang Z."/>
</authorList>
<dbReference type="PubMed" id="19881509"/>
<dbReference type="DOI" id="10.1038/ni.1815"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>UBIQUITINATION OF MAVS</scope>
<scope>INTERACTION WITH PCBP2</scope>
<scope>MUTAGENESIS OF CYS-871</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Am. J. Hum. Genet." volume="86" first="447" last="453">
<title>Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease.</title>
<authorList>
<person name="Lohr N.J."/>
<person name="Molleston J.P."/>
<person name="Strauss K.A."/>
<person name="Torres-Martinez W."/>
<person name="Sherman E.A."/>
<person name="Squires R.H."/>
<person name="Rider N.L."/>
<person name="Chikwava K.R."/>
<person name="Cummings O.W."/>
<person name="Morton D.H."/>
<person name="Puffenberger E.G."/>
</authorList>
<dbReference type="PubMed" id="20170897"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2010.01.028"/>
</citation>
<scope>INVOLVEMENT IN ADMFD</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="FEBS J." volume="277" first="2803" last="2814">
<title>The E3 ubiquitin ligase Itch regulates sorting nexin 9 through an unconventional substrate recognition domain.</title>
<authorList>
<person name="Baumann C."/>
<person name="Lindholm C.K."/>
<person name="Rimoldi D."/>
<person name="Levy F."/>
</authorList>
<dbReference type="PubMed" id="20491914"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2010.07698.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH SNX9 AND SNX18</scope>
<scope>UBIQUITINATION OF SNX9</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="FEBS J." volume="277" first="1319" last="1330">
<title>The ubiquitin ligase Itch mediates the antiapoptotic activity of epidermal growth factor by promoting the ubiquitylation and degradation of the truncated C-terminal portion of Bid.</title>
<authorList>
<person name="Azakir B.A."/>
<person name="Desrochers G."/>
<person name="Angers A."/>
</authorList>
<dbReference type="PubMed" id="20392206"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2010.07562.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH P15 BID</scope>
<scope>UBIQUITINATION OF P15 BID</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="8869" last="8879">
<title>The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation.</title>
<authorList>
<person name="Zhang P."/>
<person name="Wang C."/>
<person name="Gao K."/>
<person name="Wang D."/>
<person name="Mao J."/>
<person name="An J."/>
<person name="Xu C."/>
<person name="Wu D."/>
<person name="Yu H."/>
<person name="Liu J.O."/>
<person name="Yu L."/>
</authorList>
<dbReference type="PubMed" id="20068034"/>
<dbReference type="DOI" id="10.1074/jbc.m109.063321"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH TXNIP</scope>
<scope>UBIQUITINATION OF TXNIP</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="1388" last="1398">
<title>Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways.</title>
<authorList>
<person name="Gilmore-Hebert M."/>
<person name="Ramabhadran R."/>
<person name="Stern D.F."/>
</authorList>
<dbReference type="PubMed" id="20858735"/>
<dbReference type="DOI" id="10.1158/1541-7786.mcr-10-0042"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH ERBB4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Virol. J." volume="7" first="179" last="179">
<title>Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch.</title>
<authorList>
<person name="Ushijima Y."/>
<person name="Luo C."/>
<person name="Kamakura M."/>
<person name="Goshima F."/>
<person name="Kimura H."/>
<person name="Nishiyama Y."/>
</authorList>
<dbReference type="PubMed" id="20682038"/>
<dbReference type="DOI" id="10.1186/1743-422x-7-179"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 2 PROTEIN UL56</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="3546" last="3556">
<title>Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding.</title>
<authorList>
<person name="Rauch S."/>
<person name="Martin-Serrano J."/>
</authorList>
<dbReference type="PubMed" id="21191027"/>
<dbReference type="DOI" id="10.1128/jvi.02045-10"/>
</citation>
<scope>INTERACTION WITH ARRDC1; ARRDC2 AND ARRDC3</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="EMBO Rep." volume="13" first="1087" last="1094">
<title>Phosphatidylinositol 4-kinase IIalpha function at endosomes is regulated by the ubiquitin ligase Itch.</title>
<authorList>
<person name="Mossinger J."/>
<person name="Wieffer M."/>
<person name="Krause E."/>
<person name="Freund C."/>
<person name="Gerth F."/>
<person name="Krauss M."/>
<person name="Haucke V."/>
</authorList>
<dbReference type="PubMed" id="23146885"/>
<dbReference type="DOI" id="10.1038/embor.2012.164"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH PI4K2A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF CYS-871</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="4599" last="4608">
<title>Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.</title>
<authorList>
<person name="Pareja F."/>
<person name="Ferraro D.A."/>
<person name="Rubin C."/>
<person name="Cohen-Dvashi H."/>
<person name="Zhang F."/>
<person name="Aulmann S."/>
<person name="Ben-Chetrit N."/>
<person name="Pines G."/>
<person name="Navon R."/>
<person name="Crosetto N."/>
<person name="Kostler W."/>
<person name="Carvalho S."/>
<person name="Lavi S."/>
<person name="Schmitt F."/>
<person name="Dikic I."/>
<person name="Yakhini Z."/>
<person name="Sinn P."/>
<person name="Mills G.B."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="22179831"/>
<dbReference type="DOI" id="10.1038/onc.2011.587"/>
</citation>
<scope>INTERACTION WITH OTUD7B</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E50557" last="E50557">
<title>Mammalian alpha arrestins link activated seven transmembrane receptors to Nedd4 family e3 ubiquitin ligases and interact with beta arrestins.</title>
<authorList>
<person name="Shea F.F."/>
<person name="Rowell J.L."/>
<person name="Li Y."/>
<person name="Chang T.H."/>
<person name="Alvarez C.E."/>
</authorList>
<dbReference type="PubMed" id="23236378"/>
<dbReference type="DOI" id="10.1371/journal.pone.0050557"/>
</citation>
<scope>INTERACTION WITH ARRDC4</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="4457" last="4468">
<title>Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals.</title>
<authorList>
<person name="Puca L."/>
<person name="Chastagner P."/>
<person name="Meas-Yedid V."/>
<person name="Israel A."/>
<person name="Brou C."/>
</authorList>
<dbReference type="PubMed" id="23886940"/>
<dbReference type="DOI" id="10.1242/jcs.130500"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ARRDC1 AND ARRDC3</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="Mol. Biol. Cell" volume="25" first="1892" last="1904">
<title>The ubiquitin ligase deltex-3l regulates endosomal sorting of the G protein-coupled receptor CXCR4.</title>
<authorList>
<person name="Holleman J."/>
<person name="Marchese A."/>
</authorList>
<dbReference type="PubMed" id="24790097"/>
<dbReference type="DOI" id="10.1091/mbc.e13-10-0612"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PATHWAY</scope>
<scope>INTERACTION WITH DTX3L</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH DTX3L; STAM AND HGS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-871</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="7141" last="7150">
<title>Nedd4 family interacting protein 1 (Ndfip1) is required for ubiquitination and nuclear trafficking of BRCA1-associated ATM activator 1 (BRAT1) during the DNA damage response.</title>
<authorList>
<person name="Low L.H."/>
<person name="Chow Y.L."/>
<person name="Li Y."/>
<person name="Goh C.P."/>
<person name="Putz U."/>
<person name="Silke J."/>
<person name="Ouchi T."/>
<person name="Howitt J."/>
<person name="Tan S.S."/>
</authorList>
<dbReference type="PubMed" id="25631046"/>
<dbReference type="DOI" id="10.1074/jbc.m114.613687"/>
</citation>
<scope>FUNCTION IN UBIQUITINATION OF BRAT1</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="J. Immunol." volume="194" first="2160" last="2167">
<title>Ndfip1 regulates itch ligase activity and airway inflammation via UbcH7.</title>
<authorList>
<person name="Kathania M."/>
<person name="Zeng M."/>
<person name="Yadav V.N."/>
<person name="Moghaddam S.J."/>
<person name="Yang B."/>
<person name="Venuprasad K."/>
</authorList>
<dbReference type="PubMed" id="25632008"/>
<dbReference type="DOI" id="10.4049/jimmunol.1402742"/>
</citation>
<scope>INTERACTION WITH UBE2L3</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2016" name="J. Virol." volume="90" first="9163" last="9171">
<title>ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.</title>
<authorList>
<person name="Han Z."/>
<person name="Sagum C.A."/>
<person name="Bedford M.T."/>
<person name="Sidhu S.S."/>
<person name="Sudol M."/>
<person name="Harty R.N."/>
</authorList>
<dbReference type="PubMed" id="27489272"/>
<dbReference type="DOI" id="10.1128/jvi.01078-16"/>
</citation>
<scope>INTERACTION WITH EBOLA VIRUS PROTEIN VP40 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2016" name="J. Gen. Virol." volume="97" first="196" last="208">
<title>Degradation of host ubiquitin E3 ligase Itch by human cytomegalovirus UL42.</title>
<authorList>
<person name="Koshizuka T."/>
<person name="Tanaka K."/>
<person name="Suzutani T."/>
</authorList>
<dbReference type="PubMed" id="26555021"/>
<dbReference type="DOI" id="10.1099/jgv.0.000336"/>
</citation>
<scope>INTERACTION WITH HCMV PROTEIN UL42 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2018" name="Sci. Rep." volume="8" first="4447" last="4447">
<title>Herpesviruses possess conserved proteins for interaction with Nedd4 family ubiquitin E3 ligases.</title>
<authorList>
<person name="Koshizuka T."/>
<person name="Kobayashi T."/>
<person name="Ishioka K."/>
<person name="Suzutani T."/>
</authorList>
<dbReference type="PubMed" id="29535361"/>
<dbReference type="DOI" id="10.1038/s41598-018-22682-2"/>
</citation>
<scope>INTERACTION WITH HHV-1 UL56 (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH VZV ORF0 (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HCMV UL42 (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HHV-6A U24 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2018" name="Virol. Sin." volume="33" first="440" last="448">
<title>CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus.</title>
<authorList>
<person name="Mahesutihan M."/>
<person name="Zheng W."/>
<person name="Cui L."/>
<person name="Li Y."/>
<person name="Jiao P."/>
<person name="Yang W."/>
<person name="Liu W."/>
<person name="Li J."/>
<person name="Fan W."/>
<person name="Yang L."/>
<person name="Liu W."/>
<person name="Sun L."/>
</authorList>
<dbReference type="PubMed" id="30328013"/>
<dbReference type="DOI" id="10.1007/s12250-018-0058-6"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INFLUENZA A VIRUS MATRIX PROTEIN 1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="28893" last="28903">
<title>A novel interaction between atrophin-interacting protein 4 and beta-p21-activated kinase-interactive exchange factor is mediated by an SH3 domain.</title>
<authorList>
<person name="Janz J.M."/>
<person name="Sakmar T.P."/>
<person name="Min K.C."/>
</authorList>
<dbReference type="PubMed" id="17652093"/>
<dbReference type="DOI" id="10.1074/jbc.m702678200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 246-270 IN COMPLEX WITH ARHGEF7</scope>
</reference>
<reference key="45">
<citation type="submission" date="2006-10" db="PDB data bank">
<title>Solution structure of the second WW domain of ITCHY homolog E3 ubiquitin protein ligase (ITCH).</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 328-357</scope>
</reference>
<comment type="function">
<text evidence="10 18 19 21 23 24 25 27 28 30 31 32 34 35 40 42 43 44 49">Acts as an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates (PubMed:14602072, PubMed:17028573, PubMed:16387660, PubMed:18718448, PubMed:18718449, PubMed:11046148, PubMed:19592251, PubMed:19116316, PubMed:19881509, PubMed:20491914, PubMed:20392206, PubMed:20068034, PubMed:23146885, PubMed:24790097, PubMed:25631046). Catalyzes 'Lys-29'-, 'Lys-48'- and 'Lys-63'-linked ubiquitin conjugation (PubMed:17028573, PubMed:18718448, PubMed:19131965, PubMed:19881509). Involved in the control of inflammatory signaling pathways (PubMed:19131965). Essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, TAX1BP1 and RNF11, that ensures the transient nature of inflammatory signaling pathways (PubMed:19131965). Promotes the association of the complex after TNF stimulation (PubMed:19131965). Once the complex is formed, TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains (PubMed:19131965). This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NFKB1 (PubMed:19131965). Ubiquitinates RIPK2 by 'Lys-63'-linked conjugation and influences NOD2-dependent signal transduction pathways (PubMed:19592251). Regulates the transcriptional activity of several transcription factors, and probably plays an important role in the regulation of immune response (PubMed:18718448, PubMed:20491914). Ubiquitinates NFE2 by 'Lys-63' linkages and is implicated in the control of the development of hematopoietic lineages (PubMed:18718448). Mediates JUN ubiquitination and degradation (By similarity). Mediates JUNB ubiquitination and degradation (PubMed:16387660). Critical regulator of type 2 helper T (Th2) cell cytokine production by inducing JUNB ubiquitination and degradation (By similarity). Involved in the negative regulation of MAVS-dependent cellular antiviral responses (PubMed:19881509). Ubiquitinates MAVS through 'Lys-48'-linked conjugation resulting in MAVS proteasomal degradation (PubMed:19881509). Following ligand stimulation, regulates sorting of Wnt receptor FZD4 to the degradative endocytic pathway probably by modulating PI42KA activity (PubMed:23146885). Ubiquitinates PI4K2A and negatively regulates its catalytic activity (PubMed:23146885). Ubiquitinates chemokine receptor CXCR4 and regulates sorting of CXCR4 to the degradative endocytic pathway following ligand stimulation by ubiquitinating endosomal sorting complex required for transport ESCRT-0 components HGS and STAM (PubMed:14602072, PubMed:23146885). Targets DTX1 for lysosomal degradation and controls NOTCH1 degradation, in the absence of ligand, through 'Lys-29'-linked polyubiquitination (PubMed:17028573, PubMed:18628966, PubMed:23886940). Ubiquitinates SNX9 (PubMed:20491914). Ubiquitinates MAP3K7 through 'Lys-48'-linked conjugation (By similarity). Involved in the regulation of apoptosis and reactive oxygen species levels through the ubiquitination and proteasomal degradation of TXNIP (PubMed:20068034). Mediates the antiapoptotic activity of epidermal growth factor through the ubiquitination and proteasomal degradation of p15 BID (PubMed:20392206). Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1 (PubMed:25631046). Inhibits the replication of influenza A virus (IAV) via ubiquitination of IAV matrix protein 1 (M1) through 'Lys-48'-linked conjugation resulting in M1 proteasomal degradation (PubMed:30328013).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="18 19 21 23 24 25 27 30 31 32 34 35 40 43 44">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.26"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="10 40 43 44">Activated by NDFIP1- and NDFIP2-binding (PubMed:25631046). Activated by PI4K2A-binding (PubMed:23146885). Inhibited by DTX3L-binding (PubMed:24790097). Inhibited by N4BP1 binding (By similarity).</text>
</comment>
<comment type="pathway" evidence="18 19 21 23 24 25 27 30 31 32 34 35 40 43 44">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="10 15 16 17 18 19 20 21 22 24 27 28 29 31 32 34 35 37 38 39 40 41 42 43 45 50">Monomer. Interacts (via WW domains) with OCNL (By similarity). Interacts (via WW domains) with NOTCH1 (By similarity). Interacts (via WW domains) with JUN (By similarity). Interacts with JUNB; the interaction promotes ITCH-mediated ubiquitination and degradation of JUNB (PubMed:16387660). Interacts with FYN; the interaction phosphorylates ITCH on Tyr-420 decreasing binding of JUNB (PubMed:16387660). Interacts (via WW domain 2) with N4BP1; the interaction inhibits the E3 ubiquitin-protein ligase activity (By similarity). Interacts with NDFIP1 and NDFIP2; this interaction activates the E3 ubiquitin-protein ligase and may induce its recruitment to exosomes (By similarity). Interacts with ARHGEF7 (PubMed:17652093). Interacts with RNF11 (PubMed:14559117, PubMed:19131965). Interacts (via the WW 1 domain) with NFE2 (via the PXY motif 1); the interaction promotes 'Lys-63'-linked ubiquitination of NFE2, retains it in the cytoplasm and prevents its transactivation activity (PubMed:11318614, PubMed:18718448). Interacts (via WW domains) with CXCR4 (via C-terminus); the interaction depends on CXCR4 phosphorylation (PubMed:19116316). Found in a complex with E3 ligase DTX3L and ESCRT-0 components HGS and STAM (PubMed:24790097). Interacts with DTX3L (via C-terminus); the interaction is increased upon CXCL12 stimulation and inhibits ITCH catalytic activity (the interaction is direct) (PubMed:24790097). Interacts with HGS (PubMed:14602072). Interacts (via WW domains) with PCBP2 within a complex containing ITCH, MAVS and PCBP2 (PubMed:19881509). Interacts (via WW domains) with TXNIP (via C-terminus) (PubMed:20068034). Interacts with p15 BID (PubMed:20392206). Interacts with ERBB4 (PubMed:20858735). Interacts with DTX1 (PubMed:17028573). Interacts with SPART (PubMed:19580544). Interacts with SNX9 and SNX18 (PubMed:20491914). Interacts (via its WW domains) with ATN1 (PubMed:9647693). Interacts (via WW domains) with SGK3 (PubMed:16888620). Interacts with CBLC (PubMed:12226085). Interacts with OTUD7B (PubMed:22179831). Interacts (via WW domain 1,2 and 3) with PI4K2A; the interaction inhibits PI4K2A catalytic activity and promotes ITCH catalytic activity (PubMed:23146885). Interacts with ARRDC4 (PubMed:23236378). Part of a complex containing ITCH, NDFIP1 and MAP3K7 (By similarity). Interacts with UBE2L3; the interaction is mediated by NDFIP1 (PubMed:25632008). Interacts with MAPK8/JNK1 (By similarity). Interacts (via WW domains) with ARRDC1 (via PPxY motifs); the interaction is direct and participates in the recruitment of the ubiquitin-protein ligase ITCH to the NOTCH1 receptor (PubMed:21191027, PubMed:23886940). Interacts (via WW domains) with ARRDC2 (PubMed:21191027). Interacts (via WW domains) with ARRDC3 (PubMed:21191027, PubMed:23886940).</text>
</comment>
<comment type="subunit">
<text evidence="14">(Microbial infection) Interacts with Epstein-Barr virus LMP2A.</text>
</comment>
<comment type="subunit">
<text evidence="46 48">(Microbial infection) Interacts with Human cytomegalovirus (HCMV) protein UL42; this interaction induces ubiquitination and degradation of ITCH.</text>
</comment>
<comment type="subunit">
<text evidence="48">(Microbial infection) Interacts with herpesvirus 1 (HHV-1) UL56 protein; this interaction induces ubiquitination and probably degradation of ITCH.</text>
</comment>
<comment type="subunit">
<text evidence="36">(Microbial infection) Interacts with herpesvirus 2 (HHV-2) UL56 protein.</text>
</comment>
<comment type="subunit">
<text evidence="48">(Microbial infection) Interacts with varicella-zoster virus (VZV) Orf0 protein.</text>
</comment>
<comment type="subunit">
<text evidence="48">(Microbial infection) Interacts with herpesvirus 6A (HHV-6A) U24 protein.</text>
</comment>
<comment type="subunit">
<text evidence="47">(Microbial infection) Interacts with ebola virus protein VP40; this interaction is required for efficient viral egress from the infected cell.</text>
</comment>
<comment type="subunit">
<text evidence="49">(Microbial infection) Interacts with influenza A virus matrix protein 1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-2875665">
<id>Q96B67</id>
<label>ARRDC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-2117940">
<id>Q9NQC7</id>
<label>CYLD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-308084">
<id>P08151</id>
<label>GLI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-5278391">
<id>O75113</id>
<label>N4BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-3239392">
<id>Q9BTU6</id>
<label>PI4K2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-396669">
<id>Q9Y3C5</id>
<label>RNF11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-2801236">
<id>Q96BR1</id>
<label>SGK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-77848">
<id>Q9Y5X1</id>
<label>SNX9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-77642">
<id>Q13625</id>
<label>TP53BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-2337775">
<id>Q9H3D4</id>
<label>TP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-389606">
<id>O15350</id>
<label>TP73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-389619">
<id>O15350-1</id>
<label>TP73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-5651259">
<id>O15350-8</id>
<label>TP73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-783400">
<id>P70444</id>
<label>Bid</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-7181113">
<id>P13285</id>
<label>LMP2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564678">
<id>Q96J02</id>
</interactant>
<interactant intactId="EBI-3896014">
<id>Q9QZS3-2</id>
<label>Numb</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6672198">
<id>Q96J02-2</id>
</interactant>
<interactant intactId="EBI-2117940">
<id>Q9NQC7</id>
<label>CYLD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6672198">
<id>Q96J02-2</id>
</interactant>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6672198">
<id>Q96J02-2</id>
</interactant>
<interactant intactId="EBI-15692884">
<id>Q15303-3</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18">Cell membrane</location>
<topology evidence="57">Peripheral membrane protein</topology>
<orientation evidence="57">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="37">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18 40 43">Early endosome membrane</location>
<topology evidence="57 58 59">Peripheral membrane protein</topology>
<orientation evidence="57 58 59">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="40">Endosome membrane</location>
<topology evidence="58">Peripheral membrane protein</topology>
<orientation evidence="58">Cytoplasmic side</orientation>
</subcellularLocation>
<text evidence="18 26 43">May be recruited to exosomes by NDFIP1 (PubMed:18819914). Localizes to plasma membrane upon CXCL12 stimulation where it co-localizes with CXCL4 (PubMed:14602072). Localization to early endosomes is increased upon CXCL12 stimulation where it co-localizes with DTX3L and CXCL4 (PubMed:24790097).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96J02-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96J02-2</id>
<name>2</name>
<sequence type="described" ref="VSP_008451"/>
</isoform>
<isoform>
<id>Q96J02-3</id>
<name>3</name>
<sequence type="described" ref="VSP_044732 VSP_008451"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Widely expressed.</text>
</comment>
<comment type="domain">
<text evidence="38">The WW domains mediate interaction with PPxY motif-containing proteins.</text>
</comment>
<comment type="PTM">
<text evidence="9 16 19 20 25">On T-cell activation, phosphorylation by the JNK cascade on serine and threonine residues surrounding the PRR domain accelerates the ubiquitination and degradation of JUN and JUNB. The increased ITCH catalytic activity due to phosphorylation by JNK1 may occur due to a conformational change disrupting the interaction between the PRR/WW motifs domain and the HECT domain and, thus exposing the HECT domain (By similarity). Phosphorylation by FYN reduces interaction with JUNB and negatively controls JUN ubiquitination and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="25 27 40 43">Monoubiquitinated (PubMed:19116316). Autopolyubiquitinated with 'Lys-63' linkages which does not lead to protein degradation (PubMed:18718449, PubMed:23146885, PubMed:24790097).</text>
</comment>
<comment type="disease" evidence="33">
<disease id="DI-02639">
<name>Autoimmune disease, multisystem, with facial dysmorphism</name>
<acronym>ADMFD</acronym>
<description>A disorder characterized by organomegaly, failure to thrive, developmental delay, dysmorphic features and autoimmune inflammatory cell infiltration of the lungs, liver and gut.</description>
<dbReference type="MIM" id="613385"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<dbReference type="EC" id="2.3.2.26" evidence="18 19 21 23 24 25 30"/>
<dbReference type="EMBL" id="AF095745">
<property type="protein sequence ID" value="AAK39399.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB056663">
<property type="protein sequence ID" value="BAB39389.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304090">
<property type="protein sequence ID" value="BAG64996.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315212">
<property type="protein sequence ID" value="BAG37647.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL109923">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356299">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76272.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76274.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76276.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006848">
<property type="protein sequence ID" value="AAH06848.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011571">
<property type="protein sequence ID" value="AAH11571.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF038564">
<property type="protein sequence ID" value="AAC04845.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13234.1">
<molecule id="Q96J02-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58768.1">
<molecule id="Q96J02-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58769.1">
<molecule id="Q96J02-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244066.1">
<molecule id="Q96J02-1"/>
<property type="nucleotide sequence ID" value="NM_001257137.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244067.1">
<molecule id="Q96J02-3"/>
<property type="nucleotide sequence ID" value="NM_001257138.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001311126.1">
<molecule id="Q96J02-1"/>
<property type="nucleotide sequence ID" value="NM_001324197.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001311127.1">
<molecule id="Q96J02-2"/>
<property type="nucleotide sequence ID" value="NM_001324198.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_113671.3">
<molecule id="Q96J02-2"/>
<property type="nucleotide sequence ID" value="NM_031483.6"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883578.1">
<molecule id="Q96J02-1"/>
<property type="nucleotide sequence ID" value="XM_017028089.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883580.1">
<molecule id="Q96J02-3"/>
<property type="nucleotide sequence ID" value="XM_017028091.1"/>
</dbReference>
<dbReference type="PDB" id="2DMV">
<property type="method" value="NMR"/>
<property type="chains" value="A=328-357"/>
</dbReference>
<dbReference type="PDB" id="2KYK">
<property type="method" value="NMR"/>
<property type="chains" value="A=359-392"/>
</dbReference>
<dbReference type="PDB" id="2NQ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1-155"/>
</dbReference>
<dbReference type="PDB" id="2P4R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="T=246-270"/>
</dbReference>
<dbReference type="PDB" id="2YSF">
<property type="method" value="NMR"/>
<property type="chains" value="A=480-512"/>
</dbReference>
<dbReference type="PDB" id="3TUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A=524-903"/>
</dbReference>
<dbReference type="PDB" id="4ROF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A/B=436-474"/>
</dbReference>
<dbReference type="PDB" id="5C7M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.03"/>
<property type="chains" value="A=524-899"/>
</dbReference>
<dbReference type="PDB" id="5CQ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=433-521"/>
</dbReference>
<dbReference type="PDB" id="5DWS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/C/E/G=436-474"/>
</dbReference>
<dbReference type="PDB" id="5DZD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.57"/>
<property type="chains" value="A/B=475-514"/>
</dbReference>
<dbReference type="PDB" id="5SXP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="F/G=249-269"/>
</dbReference>
<dbReference type="PDBsum" id="2DMV"/>
<dbReference type="PDBsum" id="2KYK"/>
<dbReference type="PDBsum" id="2NQ3"/>
<dbReference type="PDBsum" id="2P4R"/>
<dbReference type="PDBsum" id="2YSF"/>
<dbReference type="PDBsum" id="3TUG"/>
<dbReference type="PDBsum" id="4ROF"/>
<dbReference type="PDBsum" id="5C7M"/>
<dbReference type="PDBsum" id="5CQ2"/>
<dbReference type="PDBsum" id="5DWS"/>
<dbReference type="PDBsum" id="5DZD"/>
<dbReference type="PDBsum" id="5SXP"/>
<dbReference type="SMR" id="Q96J02"/>
<dbReference type="BioGRID" id="123747">
<property type="interactions" value="238"/>
</dbReference>
<dbReference type="CORUM" id="Q96J02"/>
<dbReference type="DIP" id="DIP-29849N"/>
<dbReference type="ELM" id="Q96J02"/>
<dbReference type="IntAct" id="Q96J02">
<property type="interactions" value="60"/>
</dbReference>
<dbReference type="MINT" id="Q96J02"/>
<dbReference type="STRING" id="9606.ENSP00000480499"/>
<dbReference type="ChEMBL" id="CHEMBL4295925"/>
<dbReference type="iPTMnet" id="Q96J02"/>
<dbReference type="PhosphoSitePlus" id="Q96J02"/>
<dbReference type="BioMuta" id="ITCH"/>
<dbReference type="DMDM" id="37537897"/>
<dbReference type="EPD" id="Q96J02"/>
<dbReference type="jPOST" id="Q96J02"/>
<dbReference type="MassIVE" id="Q96J02"/>
<dbReference type="MaxQB" id="Q96J02"/>
<dbReference type="PaxDb" id="Q96J02"/>
<dbReference type="PeptideAtlas" id="Q96J02"/>
<dbReference type="PRIDE" id="Q96J02"/>
<dbReference type="ProteomicsDB" id="25826"/>
<dbReference type="ProteomicsDB" id="76882">
<molecule id="Q96J02-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="76883">
<molecule id="Q96J02-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="10897">
<property type="antibodies" value="298 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="Q96J02">
<property type="antibodies" value="3 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000262650">
<molecule id="Q96J02-1"/>
<property type="protein sequence ID" value="ENSP00000262650"/>
<property type="gene ID" value="ENSG00000078747"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000374864">
<molecule id="Q96J02-2"/>
<property type="protein sequence ID" value="ENSP00000363998"/>
<property type="gene ID" value="ENSG00000078747"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000535650">
<molecule id="Q96J02-3"/>
<property type="protein sequence ID" value="ENSP00000445608"/>
<property type="gene ID" value="ENSG00000078747"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000665346">
<molecule id="Q96J02-1"/>
<property type="protein sequence ID" value="ENSP00000499786"/>
<property type="gene ID" value="ENSG00000078747"/>
</dbReference>
<dbReference type="GeneID" id="83737"/>
<dbReference type="KEGG" id="hsa:83737"/>
<dbReference type="UCSC" id="uc002xak.3">
<molecule id="Q96J02-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="83737"/>
<dbReference type="DisGeNET" id="83737"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000078747.12"/>
<dbReference type="GeneCards" id="ITCH"/>
<dbReference type="HGNC" id="HGNC:13890">
<property type="gene designation" value="ITCH"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000078747">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="ITCH"/>
<dbReference type="MIM" id="606409">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613385">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96J02"/>
<dbReference type="OpenTargets" id="ENSG00000078747"/>
<dbReference type="Orphanet" id="228426">
<property type="disease" value="Syndromic multisystem autoimmune disease due to Itch deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29934"/>
<dbReference type="eggNOG" id="KOG0940">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157014"/>
<dbReference type="HOGENOM" id="CLU_002173_0_1_1"/>
<dbReference type="InParanoid" id="Q96J02"/>
<dbReference type="KO" id="K05632"/>
<dbReference type="OMA" id="RQIVWFW"/>
<dbReference type="OrthoDB" id="167687at2759"/>
<dbReference type="PhylomeDB" id="Q96J02"/>
<dbReference type="TreeFam" id="TF323658"/>
<dbReference type="BRENDA" id="6.3.2.19">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q96J02"/>
<dbReference type="Reactome" id="R-HSA-1253288">
<property type="pathway name" value="Downregulation of ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2122948">
<property type="pathway name" value="Activated NOTCH1 Transmits Signal to the Nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5610780">
<property type="pathway name" value="Degradation of GLI1 by the proteasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5632684">
<property type="pathway name" value="Hedgehog 'on' state"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939236">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of HSCs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of DDX58/IFIH1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SignaLink" id="Q96J02"/>
<dbReference type="SIGNOR" id="Q96J02"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="83737">
<property type="hits" value="6 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ITCH">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q96J02"/>
<dbReference type="GenomeRNAi" id="83737"/>
<dbReference type="Pharos" id="Q96J02">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96J02"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="RNAct" id="Q96J02">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000078747">
<property type="expression patterns" value="Expressed in sperm and 232 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96J02">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96J02">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990763">
<property type="term" value="F:arrestin family protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045236">
<property type="term" value="F:CXCR chemokine receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016874">
<property type="term" value="F:ligase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043021">
<property type="term" value="F:ribonucleoprotein complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044389">
<property type="term" value="F:ubiquitin-like protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046642">
<property type="term" value="P:negative regulation of alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050687">
<property type="term" value="P:negative regulation of defense response to virus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046329">
<property type="term" value="P:negative regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000646">
<property type="term" value="P:positive regulation of receptor catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002669">
<property type="term" value="P:positive regulation of T cell anergy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051865">
<property type="term" value="P:protein autoubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035519">
<property type="term" value="P:protein K29-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070936">
<property type="term" value="P:protein K48-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070534">
<property type="term" value="P:protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001558">
<property type="term" value="P:regulation of cell growth"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902036">
<property type="term" value="P:regulation of hematopoietic stem cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090085">
<property type="term" value="P:regulation of protein deubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046718">
<property type="term" value="P:viral entry into host cell"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00078">
<property type="entry name" value="HECTc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00201">
<property type="entry name" value="WW"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00178"/>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035892">
<property type="entry name" value="C2_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR024928">
<property type="entry name" value="E3_ub_ligase_SMURF1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000569">
<property type="entry name" value="HECT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035983">
<property type="entry name" value="Hect_E3_ubiquitin_ligase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001202">
<property type="entry name" value="WW_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036020">
<property type="entry name" value="WW_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00168">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00632">
<property type="entry name" value="HECT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00397">
<property type="entry name" value="WW"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001569">
<property type="entry name" value="E3_ub_ligase_SMURF1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00239">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00119">
<property type="entry name" value="HECTc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00456">
<property type="entry name" value="WW"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51045">
<property type="entry name" value="SSF51045"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56204">
<property type="entry name" value="SSF56204"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50004">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50237">
<property type="entry name" value="HECT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01159">
<property type="entry name" value="WW_DOMAIN_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50020">
<property type="entry name" value="WW_DOMAIN_2"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="initiator methionine" description="Removed" evidence="8">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="E3 ubiquitin-protein ligase Itchy homolog" id="PRO_0000120317">
<location>
<begin position="2"/>
<end position="903"/>
</location>
</feature>
<feature type="domain" description="C2" evidence="11">
<location>
<begin position="1"/>
<end position="115"/>
</location>
</feature>
<feature type="domain" description="WW 1" evidence="13">
<location>
<begin position="326"/>
<end position="359"/>
</location>
</feature>
<feature type="domain" description="WW 2" evidence="13">
<location>
<begin position="358"/>
<end position="391"/>
</location>
</feature>
<feature type="domain" description="WW 3" evidence="13">
<location>
<begin position="438"/>
<end position="471"/>
</location>
</feature>
<feature type="domain" description="WW 4" evidence="13">
<location>
<begin position="478"/>
<end position="511"/>
</location>
</feature>
<feature type="domain" description="HECT" evidence="12">
<location>
<begin position="569"/>
<end position="903"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with FYN" evidence="19">
<location>
<begin position="395"/>
<end position="471"/>
</location>
</feature>
<feature type="region of interest" description="MAP kinase docking site" evidence="9">
<location>
<begin position="574"/>
<end position="583"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Pro-rich (PRR domain)">
<location>
<begin position="252"/>
<end position="267"/>
</location>
</feature>
<feature type="active site" description="Glycyl thioester intermediate" evidence="12">
<location>
<position position="871"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="8">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK8" evidence="10">
<location>
<position position="240"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK8" evidence="10">
<location>
<position position="263"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK8" evidence="10">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by SGK3" evidence="20">
<location>
<position position="385"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FYN" evidence="19">
<location>
<position position="420"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by SGK3" evidence="20">
<location>
<position position="450"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_044732" evidence="52">
<location>
<begin position="1"/>
<end position="110"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_008451" evidence="51 52 53 54 55">
<original>NGVSLCLPRLECNSAISAHCNLCLPGLSDSPISASRVAGFTG</original>
<variation>S</variation>
<location>
<begin position="159"/>
<end position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation on T-cell stimulation nor in the presence of FYN." evidence="19">
<original>Y</original>
<variation>F</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced phosphorylation on T-cell stimulation and in the presence of FYN. Increased ITCH-mediated Ub conjugation and degradation of JUNB." evidence="19">
<original>Y</original>
<variation>F</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation on T-cell stimulation nor in the presence of FYN." evidence="19">
<original>Y</original>
<variation>F</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitin protein ligase activity. Results in altered endosomal sorting and reduced degradation of CXCR4. Unable to inhibit MAVS-induced activation of INFB." evidence="14 18 31 40 43">
<original>C</original>
<variation>A</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG64996." ref="3" evidence="56">
<original>T</original>
<variation>I</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="18"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="41"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="50"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="64"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="78"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="93"/>
<end position="101"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="102"/>
<end position="108"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="112"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="130"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="332"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="342"/>
<end position="346"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="347"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="352"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="365"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="374"/>
<end position="377"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="379"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="444"/>
<end position="448"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="454"/>
<end position="458"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="459"/>
<end position="462"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="463"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="484"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="494"/>
<end position="498"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="499"/>
<end position="502"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="503"/>
<end position="507"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="509"/>
<end position="511"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="528"/>
<end position="539"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="540"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="545"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="554"/>
<end position="556"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="557"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="572"/>
<end position="574"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="575"/>
<end position="580"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="589"/>
<end position="603"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="607"/>
<end position="609"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="611"/>
<end position="614"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="621"/>
<end position="624"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="626"/>
<end position="630"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="634"/>
<end position="650"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="661"/>
<end position="667"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="675"/>
<end position="677"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="678"/>
<end position="680"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="682"/>
<end position="692"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="696"/>
<end position="699"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="704"/>
<end position="709"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="716"/>
<end position="721"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="724"/>
<end position="726"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="731"/>
<end position="733"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="735"/>
<end position="747"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="751"/>
<end position="764"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="767"/>
<end position="770"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="775"/>
<end position="783"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="790"/>
<end position="795"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="798"/>
<end position="801"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="807"/>
<end position="818"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="821"/>
<end position="832"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="842"/>
<end position="844"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="848"/>
<end position="851"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="855"/>
<end position="858"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="867"/>
<end position="869"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="870"/>
<end position="872"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="874"/>
<end position="877"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="883"/>
<end position="895"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DMV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KYK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2NQ3"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3TUG"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5C7M"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CQ2"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DWS"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8C863"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00041"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00104"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00224"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11046148"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11318614"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12226085"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14559117"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14602072"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16387660"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16888620"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17028573"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17652093"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18628966"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18718448"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18718449"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18819914"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19116316"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19131965"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19580544"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19592251"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19881509"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20068034"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20170897"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20392206"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20491914"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20682038"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20858735"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21191027"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22179831"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23146885"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23236378"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23886940"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24790097"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25631046"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25632008"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26555021"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27489272"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29535361"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30328013"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9647693"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11318614"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9647693"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="56" type="ECO:0000305"/>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14602072"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23146885"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="24790097"/>
</source>
</evidence>
<sequence length="903" mass="102803" checksum="6777A2043C7B67BC" modified="2003-10-03" version="2">MSDSGSQLGSMGSLTMKSQLQITVISAKLKENKKNWFGPSPYVEVTVDGQSKKTEKCNNTNSPKWKQPLTVIVTPVSKLHFRVWSHQTLKSDVLLGTAALDIYETLKSNNMKLEEVVVTLQLGGDKEPTETIGDLSICLDGLQLESEVVTNGETTCSENGVSLCLPRLECNSAISAHCNLCLPGLSDSPISASRVAGFTGASQNDDGSRSKDETRVSTNGSDDPEDAGAGENRRVSGNNSPSLSNGGFKPSRPPRPSRPPPPTPRRPASVNGSPSATSESDGSSTGSLPPTNTNTNTSEGATSGLIIPLTISGGSGPRPLNPVTQAPLPPGWEQRVDQHGRVYYVDHVEKRTTWDRPEPLPPGWERRVDNMGRIYYVDHFTRTTTWQRPTLESVRNYEQWQLQRSQLQGAMQQFNQRFIYGNQDLFATSQSKEFDPLGPLPPGWEKRTDSNGRVYFVNHNTRITQWEDPRSQGQLNEKPLPEGWEMRFTVDGIPYFVDHNRRTTTYIDPRTGKSALDNGPQIAYVRDFKAKVQYFRFWCQQLAMPQHIKITVTRKTLFEDSFQQIMSFSPQDLRRRLWVIFPGEEGLDYGGVAREWFFLLSHEVLNPMYCLFEYAGKDNYCLQINPASYINPDHLKYFRFIGRFIAMALFHGKFIDTGFSLPFYKRILNKPVGLKDLESIDPEFYNSLIWVKENNIEECDLEMYFSVDKEILGEIKSHDLKPNGGNILVTEENKEEYIRMVAEWRLSRGVEEQTQAFFEGFNEILPQQYLQYFDAKELEVLLCGMQEIDLNDWQRHAIYRHYARTSKQIMWFWQFVKEIDNEKRMRLLQFVTGTCRLPVGGFADLMGSNGPQKFCIEKVGKENWLPRSHTCFNRLDLPPYKSYEQLKEKLLFAIEETEGFGQE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

